Incidence of intermediate syndrome in organophosphorous poisoning.

No Thumbnail Available
Date
1995-05-01
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Seventy two patients admitted to the Intensive Care Unit following ingestion of organophosphorus compounds were studied prospectively with two different doses of pralidoxime (PAM). One group received 1 gm immediately after admission and no further PAM and the other group received infusion of PAM, 1 gm 8 hourly for four days (total 12 gms). The incidence of type II paralysis or intermediate syndrome was 47%. We observed a higher incidence in the 4 days of infusion of PAM group (61%) (20 patients) as compared to the single Bolus dose group (39%) (13 patients). Relative risk 1.48 (confidence interval = 0.9-2.4).
Description
Keywords
Citation
Samuel J, Thomas K, Jeyaseelan L, Peter JV, Cherian AM. Incidence of intermediate syndrome in organophosphorous poisoning. Journal of the Association of Physicians of India. 1995 May; 43(5): 321-3
URI
https://imsear.searo.who.int/handle/123456789/90713
Collections
Journal of the Association of Physicians of India